[H-].[Na+].[F:3][C:4]1[CH:18]=[C:17]([CH2:19][OH:20])[CH:16]=[CH:15][C:5]=1[O:6][C:7]1[CH:8]=[N:9][CH:10]=[C:11]([CH:14]=1)[C:12]#[N:13].Cl[C:22]1[CH:23]=[C:24]2[N:31]([CH3:32])[CH2:30][CH2:29][N:25]2[C:26](=[O:28])[N:27]=1>C1COCC1>[F:3][C:4]1[CH:18]=[C:17]([CH2:19][O:20][C:22]2[CH:23]=[C:24]3[N:31]([CH3:32])[CH2:30][CH2:29][N:25]3[C:26](=[O:28])[N:27]=2)[CH:16]=[CH:15][C:5]=1[O:6][C:7]1[CH:8]=[N:9][CH:10]=[C:11]([CH:14]=1)[C:12]#[N:13]Prepared in a manner similar to that described for E1 using NaH (5.90 mg, 0.246 mmol) in THF (5 mL) was added 5-(2-fluoro-4-(hydroxymethyl)phenoxy)n-icotinonitrile (30 mg, 0.12 mmol) and 7-chloro-1-methyl-2,3-dihydroimidazo[1,2-c]pyr-imidin-5(1H)-one (22.8 mg, 0.123 mmol).
Loading…